Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (7155)	4/3/1998 1:08:00 AM
From: John Zwiener	Read Replies (2) \| Respond to of 8116

No update since the news was to be expected, UNLESS the accounts found less money than was expected. I knew they were very short of money; that's why I thought the news of not filing ALT was good news (if the company folded, ALT would be tied up potentially for a year or more). Since cyto has revenue, it makes sense they could reduce spending enough to generate a profit. They claim to be close anyway. I only put in a relatively small amount since I think if management is too slow, this company could easily go under, and the shares go to zero. But if they get good advice and follow it, they can keep afloat long enough for revenues to grow faster. Then they can get a decent financing deal and get the PSMA test royalties which should be on the horizon by then. Also ALT can be filed. The PSMA technology is the reason I am interested in this company. They seem close to self-sustaining and growth if they tear up their credit cards. Have to wait. And no, this does not have the potential story of Igen. I agree.